Aleación aluminio 1350, Tso̲kwa menudo bí thogi referencia komongu “1350 he̲'mi aluminio”, ge 'nar aleación aluminio binu ko 'nar contenido mínimo aluminio ar 99.5%. Nu'bu̲ bien ar aluminio binu hingi ar usa comúnmente ja ar empaque farmacéutico, Aluminio ne yá aleaciones (Incluido 1350 aluminio) Ar tsa̲ da utilizar jar envases farmacéuticos 'mefa xta 'nar procesamiento ne recubrimiento adecuados.
Pharmaceutical packaging requires certain properties to ensure the safety and preservation of pharmaceuticals, ngu:
Barrier Properties: Packaging materials should provide a barrier against moisture, oxígeno, and other environmental factors to protect the drug product.
Sterility: Pharmaceutical packaging should maintain the sterility of the contents and prevent contamination.
Printability: Packaging materials should be capable of high-quality printing to display important information, branding, and instructions.
Ease of sealing: Packaging materials should be easy to seal securely to prevent tampering and maintain product integrity.
Safety: The material should be safe for direct contact with the drug and should not react with the drug or leach harmful substances into the drug.
He̲'mi aluminio binu (Incluido 1350 aluminio) may not meet all of these requirements without additional processing and coatings. Típicamente, pharmaceutical packaging uses specially treated and coated aluminum foil to enhance its barrier properties, sealing properties and printability.
